<DOC>
	<DOCNO>NCT01416831</DOCNO>
	<brief_summary>The purpose study compare response rate patient metastatic melanoma treat high-dose IL-2 patient treat high-dose IL-2 along radiation therapy .</brief_summary>
	<brief_title>Comparison High-dose IL-2 High-dose IL-2 With Radiation Therapy Patients With Metastatic Melanoma .</brief_title>
	<detailed_description>All patient receive high-dose IL-2 . Half patient enrol randomly select receive radiation therapy three tumor prior receive high-dose IL-2 . Among first 20 patient enrol , assign receive radiation receive single dose radiation patient 21-44 , assigned receive radiation receive 2 dos radiation .</detailed_description>
	<mesh_term>Melanoma</mesh_term>
	<mesh_term>Interleukin-2</mesh_term>
	<criteria>Histological confirmation melanoma require previous biopsy cytology . Patients must â‰¥ 18 year age . Patients must tumor amenable SBRT lung , mediastinum , chest wall , bone ( long bone ) , liver ( inclusive immediately adjacent mass ) , 1 3 focus ; minimum size , none great 7 cm . Patients may metastases maximum 3 treat . ECOG performance status 01 . Women childbearing potential must serum urine pregnancy test perform within 72 hour prior start protocol treatment . The result test must negative order patient eligible . In addition , woman childbearing potential well male patient must agree take appropriate precaution avoid pregnancy . Patients must sign studyspecific consent form . No metastatic site amenable SBRT . Patients brain metastasis candidate radiosurgery . Previous radiation site propose radiation part study . Patients active systemic , pulmonary , pericardial infection . Pregnant lactating woman . Evidence ischemia exercise tolerance test , stress thallium study , baseline EKG . DLCO , FEV1 FEV1/FVC le 70 % predict due clinically significant underlying pulmonary disease . For pulmonary function test value less predicted value , PI review , document patient 's suitability high dose IL2 therapy . WBC &lt; 3.0 x 109/L Hgb &lt; 9.0 g/dL AST/ALT &gt; 3 time upper limit normal range total bilirubin &gt; 1.9 g/dL creatinine &gt; 1.9 g/dL Patient require chronic steroid .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>metastatic melanoma</keyword>
	<keyword>IL-2</keyword>
	<keyword>Interleukin 2</keyword>
	<keyword>Radiation</keyword>
	<keyword>Stereotactic Body Radiation Treatment</keyword>
	<keyword>SBRT</keyword>
	<keyword>Immunotherapy</keyword>
</DOC>